Delcath Systems Boosts Investor Confidence with Fresh Executive Option Grants, Including 22,500‑Share Deal for New Director Sylvester John Richard.
Delcath’s insider option grants boost investor confidence, showing leadership commitment to long‑term growth and potential upside in liver‑cancer treatments.
3 minutes to read
